Search details
1.
Inhibition of de novo lipogenesis targets androgen receptor signaling in castration-resistant prostate cancer.
Proc Natl Acad Sci U S A
; 116(2): 631-640, 2019 01 08.
Article
in English
| MEDLINE | ID: mdl-30578319
2.
Synthetic lethality of combined glutaminase and Hsp90 inhibition in mTORC1-driven tumor cells.
Proc Natl Acad Sci U S A
; 112(1): E21-9, 2015 Jan 06.
Article
in English
| MEDLINE | ID: mdl-25524627
3.
Discovery and characterization of a selective IKZF2 glue degrader for cancer immunotherapy.
Cell Chem Biol
; 30(3): 235-247.e12, 2023 03 16.
Article
in English
| MEDLINE | ID: mdl-36863346
4.
The role of AMP-activated protein kinase in the coordination of skeletal muscle turnover and energy homeostasis.
Am J Physiol Cell Physiol
; 303(5): C475-85, 2012 Sep 01.
Article
in English
| MEDLINE | ID: mdl-22700795
5.
AMPK promotes skeletal muscle autophagy through activation of forkhead FoxO3a and interaction with Ulk1.
J Cell Biochem
; 113(2): 695-710, 2012 Feb.
Article
in English
| MEDLINE | ID: mdl-22006269
6.
The initiation factor eIF3-f is a major target for atrogin1/MAFbx function in skeletal muscle atrophy.
EMBO J
; 27(8): 1266-76, 2008 Apr 23.
Article
in English
| MEDLINE | ID: mdl-18354498
7.
Appetite for destruction: the inhibition of glycolysis as a therapy for tuberous sclerosis complex-related tumors.
BMC Biol
; 9: 69, 2011 Oct 21.
Article
in English
| MEDLINE | ID: mdl-22018140
8.
H3B-8800, an orally available small-molecule splicing modulator, induces lethality in spliceosome-mutant cancers.
Nat Med
; 24(4): 497-504, 2018 05.
Article
in English
| MEDLINE | ID: mdl-29457796
9.
The mTORC1/S6K1 pathway regulates glutamine metabolism through the eIF4B-dependent control of c-Myc translation.
Curr Biol
; 24(19): 2274-80, 2014 Oct 06.
Article
in English
| MEDLINE | ID: mdl-25220053
10.
Estradiol and mTORC2 cooperate to enhance prostaglandin biosynthesis and tumorigenesis in TSC2-deficient LAM cells.
J Exp Med
; 211(1): 15-28, 2014 Jan 13.
Article
in English
| MEDLINE | ID: mdl-24395886
11.
eIF3f: a central regulator of the antagonism atrophy/hypertrophy in skeletal muscle.
Int J Biochem Cell Biol
; 45(10): 2158-62, 2013 Oct.
Article
in English
| MEDLINE | ID: mdl-23769948
12.
SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage by inhibiting mitochondrial glutamine metabolism.
Cancer Cell
; 23(4): 450-63, 2013 Apr 15.
Article
in English
| MEDLINE | ID: mdl-23562301
13.
Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism.
Cancer Res
; 73(14): 4429-38, 2013 Jul 15.
Article
in English
| MEDLINE | ID: mdl-23687346
14.
Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.
PLoS One
; 5(4): e10070, 2010 Apr 07.
Article
in English
| MEDLINE | ID: mdl-20383279
15.
The translation regulatory subunit eIF3f controls the kinase-dependent mTOR signaling required for muscle differentiation and hypertrophy in mouse.
PLoS One
; 5(2): e8994, 2010 Feb 01.
Article
in English
| MEDLINE | ID: mdl-20126553
16.
MAFbx/Atrogin-1 controls the activity of the initiation factor eIF3-f in skeletal muscle atrophy by targeting multiple C-terminal lysines.
J Biol Chem
; 284(7): 4413-21, 2009 Feb 13.
Article
in English
| MEDLINE | ID: mdl-19073596
17.
Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.
PLoS One
; 4(3): e4973, 2009.
Article
in English
| MEDLINE | ID: mdl-19319192
18.
eIF3-f function in skeletal muscles: to stand at the crossroads of atrophy and hypertrophy.
Cell Cycle
; 7(12): 1698-701, 2008 Jun 15.
Article
in English
| MEDLINE | ID: mdl-18583931
19.
Papel de la adrenomedulina cerebelosa en la hipertensión arterial / Paper of the adrenomedulina cerebelosa in the arterial hypertension
Arch. venez. farmacol. ter
; 26(2): 98-104, 2007. ilus, graf
Article
in Spanish
| LILACS | ID: lil-516927
Results
1 -
19
de 19
1
Next >
>>